Mosby's 2014 Nursing Drug Reference (294 page)

BOOK: Mosby's 2014 Nursing Drug Reference
7.22Mb size Format: txt, pdf, ePub
HIGH ALERT
nitroprusside (Rx)

(nye-troe-pruss′ide)

Nitropress

Func. class.:
Antihypertensive, vasodilator

ACTION:

Directly relaxes arteriolar, venous smooth muscle, thereby resulting in reduction in cardiac preload and afterload

USES:

Hypertensive crisis; to decrease bleeding by creating hypotension during surgery; acute CHF

Unlabeled uses:
Postoperative hypertension, mitral regurgitation

CONTRAINDICATIONS:

Hypersensitivity, hypertension (compensatory) due to aortic coarctation or AV shunting, acute CHF associated with reduced pe
ripheral vascular resistance, AV shunt, Leber’s disease, toxic amblyopia

 

Black Box Warning:

Cyanide toxicity

Precautions:
Pregnancy (C), breastfeeding, children, geriatric patients, fluid, electrolyte imbalances, renal/hepatic disease, hypothyroidism

 

Black Box Warning:

Hypotension

DOSAGE AND ROUTES
Calculator

• Adult and child:
IV INF
0.25-10 mcg/kg/min; max 10 mcg/kg/min

Renal dose

• Adult:
IV INF
CCr <60 ml/min, maintain doses <3 mcg/kg/min to reduce thiocyanate accumulation

Available forms:
Inj 50 mg/2 ml

Administer:

• 
Antidote is sodium thiosulfate

Continuous IV INF route

• 
Depending on B/P reading q15min

• 
Reconstitute 50 mg/2-3 ml of D
5
W, further dilute in 250, 500, or 1000 ml of D
5
W to 200, 100, 50 mcg/ml, respectively; use inf pump only; wrap bottle with aluminum foil to protect from light; observe for color change in inf; discard if highly discolored (blue, green, dark red); titrate to patient response

Y-site compatibilities:
Alfentanil, alprostadil, amikacin, aminocaproic acid, aminophylline, amphotericin B lipid compex, amphotericin B liposome, anidulafungin, argatroban, atenolol, atropine, aztreonam, benztropine, bivalirudin, bleomycin, bumetanide, buprenorphine, butorphanol, calcium chloride/gluconate, CARBOplatin, cefamandole, ceFAZolin, cefmetazole, cefonicid, cefoperazone, cefotaxime, cefoTEtan, cefOXitin, cefTAZidime, ceftizoxime, cefTRIAXone, cefuroxime, cephalothin, chloramphenicol, cimetidine, CISplatin, clindamycin, cyanocobalamin, cyclophosphamide, cycloSPORINE, cytarabine, DACTINomycin, DAPTOmycin, dexamethasone, digoxin, diltiazem, DOCEtaxel, DOPamine, doxacurium, DOXOrubicin, doxycycline, enalaprilat, ePHEDrine, EPINEPHrine, epirubicin, epoetin alfa, eptifibatide, ertapenem, esmolol, etoposide, famotidine, fenoldopam, fentaNYL, fluconazole, fludarabine, fluorouracil, folic acid, furosemide, ganciclovir, gatifloxacin, gemcitabine, gemtuzumab, gentamicin, glycopyrrolate, granisetron, heparin, hydrocortisone, HYDROmorphone, IDArubicin, ifosfamide, inamrinone, indomethacin, insulin (regular), isoproterenol, ketorolac, labetalol, lidocaine, linezolid, LORazepam, magnesium sulfate, mannitol, mechlorethamine, meperidine, metaraminol, methicillin, methoxamine, methyldopate, methylPREDNISolone, metoclopramide, metoprolol, metroNIDAZOLE, mezlocillin, micafungin, miconazole, midazolam, milrinone, minocycline, morphine, moxalactam, multiple vitamins injection, nafcillin, nalbuphine, naloxone, nesiritide, netilmicin, niCARdipine, nitroglycerin, norepinephrine, octreotide, ondansetron, oxacillin, oxaliplatin, oxytocin, PACLitaxel, palonosetron, pamidronate, pancuronium, pantoprazole, penicillin G potassium/sodium, pentamidine, PENTobarbital, PHENobarbital, phentolamine, phenylephrine, phytonadione, piperacillin, piperacillin-tazobactam, polymyxin B, potassium chloride/phosphates, procainamide, propofol, propranolol, protamine, pyridoxine, ranitidine, ritodrine, rocuronium, sodium acetate/bicarbonate, succinylcholine, SUFentanil, tacrolimus, teniposide, theophylline, thiamine, ticarcillin, ticarcillin-clavulanate, tigecycline, tirofiban, tobramycin, tolazoline, trimetaphan, urokinase, vancomycin, vasopressin, vecuronium, verapamil, vinCRIStine, zoledronic acid

SIDE EFFECTS

CNS:
Dizziness, headache
, agitation, twitching, decreased reflexes, restlessness

CV:
Bradycardia, ECG changes, tachycardia, hypotension

GI:
Nausea, vomiting, abdominal pain

INTEG:
Pain, irritation at inj site, sweating

MISC:
Cyanide, thiocyanate toxicity,
flushing, hypothyroidism

PHARMACOKINETICS

IV:
Onset 1-2 min, duration 1-10 min, half-life 3 days in patients with abnormal renal function, circulating half-life 2 min; metabolized in liver, excreted in urine

INTERACTIONS

Increase: severe hypotension—ganglionic blockers, volatile liquid anesthetics, halothane, enflurane, circulatory depressants

Drug/Herb

Increase:
antihypertensive effect—hawthorn

NURSING CONSIDERATIONS
Assess:

• 
Electrolytes: potassium, sodium, chloride, CO
2
, CBC, serum glucose, serum methemoglobin if pulmonary O
2
levels are decreased; use IV 1-2 mg/kg methylene blue given over several min for methemoglobinemia

• 
Renal studies: catecholamines, BUN, creatinine

• 
Hepatic studies: AST, ALT, alk phos

 

Black Box Warning:

Hypotension:
B/P by direct means if possible; check ECG continuously; pulse, jugular venous distention; PCWP; rebound hypertension may occur after nitroprusside is discontinued, give only with emergency equipment nearby, rapid decrease in B/P may occur

• 
Weight daily, I&O

 
Thiocyanate, lactate, cyanide toxicity:
obtain levels daily if inf >3 mcg/kg/min; thiocyanate level should be ≤1 mmol/L; thiocyanate toxicity includes confusion, weakness, seizures, hyperreflexia, psychosis, tinnitus, coma

• 
Nausea, vomiting, diarrhea

• 
Edema in feet, legs daily; skin turgor, dryness of mucous membranes for hydration status

• 
Crackles, dyspnea, orthopnea q30min

• 
For decrease in bicarbonate, P
CO
2
blood pH, acidosis

Evaluate:

• 
Therapeutic response: decreased B/P, decreasing symptoms of cardiogenic shock or cardiac pump failure

Teach patient/family:

• 
To report headache, dizziness, loss of hearing, blurred vision, dyspnea, faintness, pain at IV site

• 
About the reason for giving product and expected results

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

nizatidine (
OTC
, Rx)

(ni-za′ti-deen)

Axid, Axid AR

Func. class.:
H
2
-receptor antagonist

Chem. class.:
Substituted thiazole

ACTION:

Blocks H
2
-receptors, thereby reducing gastric acid output

USES:

Benign gastric and duodenal ulceration, prevention of duodenal ulcer recurrence, symptomatic relief of gastroesophageal reflux, heartburn prevention

CONTRAINDICATIONS:

Hypersensitivity

Precautions:
Pregnancy (B), breastfeeding, renal/hepatic impairment (reduce dose in renal impairment)

DOSAGE AND ROUTES
Calculator
Gastric and duodenal ulcer

• Adult:
PO
300 mg at night or 150 mg bid for 4-8 wk; maintenance 150 mg at night

Prophylaxis of duodenal ulcer

• Adult:
PO
150 mg/day at bedtime

Gastroesophageal reflux

• Adult and child ≥12 yr:
PO
150 mg bid × ≤12 wk, max 300 mg/day

Heartburn prevention

• Adult:
PO
75 mg before eating bid

Renal dose

• Adult:
PO
CCr 20-50 ml/min, give 150 mg every other day; CCr <20 ml/min, give 150 mg q72hr

Available forms:
Caps 150, 300 mg; tabs 75 mg

Administer:

• 
With meals for prolonged product effect; antacids 1 hr before or 1 hr after product; at bedtime if taken daily

SIDE EFFECTS

CNS:
Headache, somnolence, confusion, abnormal dreams, dizziness

CV:
Cardiac dysrhythmias, cardiac arrest

ENDO:
Gynecomastia

GI:
Elevated hepatic enzymes,
hepatitis,
jaundice, nausea

HEMA:
Thrombocytopenia, agranulocytosis, aplastic anemia

INTEG:
Pruritus, sweating, urticaria,
exfoliative dermatitis

METAB:
Hyperuricemia

MS:
Myalgia

RESP:
Bronchospasm, laryngeal edema, pneumonia

PHARMACOKINETICS

Partially metabolized by liver, excreted by kidneys, plasma half-life 1-2.8 hr, 70% absorbed orally, small amount (0.1% of plasma concentration) enters breast milk, 35% bound to plasma proteins

INTERACTIONS

Increase:
GI obstruction risk—NIFEdipine (ext rel tabs)

Increase:
effect of—mefloquine

Decrease:
effect of—ketoconazole, itraconazole, atazanavir, cefditoren, cefpodoxime, delavirdine, gefitinib, raltegravir

Drug/Lab Test

Increase:
ALT, AST, serum creatinine

False negative:
allergy skin tests

NURSING CONSIDERATIONS
Assess:

• 
GI pain:
epigastric, abdominal, character, alleviating factors, hematemesis, occult blood in stool, heartburn, GERD

 
Agranulocytosis:
CBC with differential if patient receiving long-term therapy

Evaluate:

• 
Decreased GI pain, heartburn, GERD; resolution of gastric, duodenal ulcers

Teach patient/family:

• 
That gynecomastia, impotence may occur, are reversible

• 
To avoid driving or other hazardous activities until stabilized on product; that dizziness may occur

• 
To avoid black pepper, caffeine, alcohol, harsh spices, extremes in temp of food

• 
To avoid OTC preparations: aspirin, cough, cold preparations

TREATMENT OF OVERDOSE:

Symptomatic and supportive therapy is recommended; activated charcoal, emesis, or lavage may reduce absorption

Other books

Beyond the Misty Shore by Vicki Hinze
Notes From Underground by Roger Scruton
Shelf Life by Stephanie Lawton
The Year My Life Broke by John Marsden
The Willing by Moreau, JJ
Westward the Dream by Judith Pella, Tracie Peterson
The Girl Below by Bianca Zander